SCHEMBL23697261

SCHEMBL23697261

Brc1cccc(-c2cccc(C3(c4ccccc4)c4ccccc4Sc4ccccc43)c2)c1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GABRG2 P18507 6/20 0.37
GABRB3 P28472 6/20 0.37
GABRA5 P31644 6/20 0.37
GABRA3 P34903 6/20 0.37
GABRA1 P14867 3/20 0.37
RAB9A P51151 3/20 0.36
NPC1 O15118 2/20 0.36
TSHR P16473 2/20 0.36
SMN1; SMN2 Q16637 2/20 0.36
TP53 P04637 1/20 0.36
IDO1 P14902 1/20 0.36
BIRC5 O15392 1/20 0.34
BCHE P06276 1/20 0.34
SLC6A3 Q01959 1/20 0.34
ALDH1A1 P00352 2/20 0.33
MAPT P10636 2/20 0.33
HPGD P15428 2/20 0.33
TDP2 O95551 1/20 0.33
MEN1 O00255 1/20 0.33
HTT P42858 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23697049 0.91 BCHE (0.37) RAB9ANPC1TSHRSMN1; SMN2TP53
SCHEMBL1645301 0.83 SMN1; SMN2 (0.43) GABRG2GABRB3GABRA5GABRA3GABRA1
SCHEMBL16787352 0.81 OPRM1 (0.37) GABRA1SMN1; SMN2BCHESLC6A3MAPT
SCHEMBL21743573 0.81 OPRM1 (0.34) SMN1; SMN2BCHESLC6A3MAPTMEN1
SCHEMBL19764708 0.81 MEN1 (0.41) RAB9ANPC1SMN1; SMN2MAPTTDP2
SCHEMBL23696826 0.79 LMNA (0.36) SMN1; SMN2BCHESLC6A3ALDH1A1MAPT
SCHEMBL28267231 0.79 NOX1 (0.41) RAB9ANPC1SMN1; SMN2IDO1BCHE
SCHEMBL12166381 0.78 L3MBTL1 (0.35) ALDH1A1MAPTHPGDMEN1KMT2A
SCHEMBL23697270 0.78 MAPK1 (0.41) GABRG2GABRB3GABRA5GABRA3GABRA1
SCHEMBL12166392 0.78 L3MBTL1 (0.37) RAB9ANPC1ALDH1A1MAPTHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230183201-A1 COMPOUND FOR ORGANIC ELECTRIC ELEMENT, ORGANIC ELECTRIC ELEMENT USING SAME, AND ELECTRONIC DEVICE HAVING SAME DUK SAN NEOLUX CO., LTD. (KR) 2023-06-15 US disclosed
US-20230183201-A1 COMPOUND FOR ORGANIC ELECTRIC ELEMENT, ORGANIC ELECTRIC ELEMENT USING SAME, AND ELECTRONIC DEVICE HAVING SAME DUK SAN NEOLUX CO., LTD. (KR) 2023-06-15 US disclosed
WO-2021149998-A1 COMPOUND FOR ORGANIC ELECTRIC ELEMENT, ORGANIC ELECTRIC ELEMENT USING SAME, AND ELECTRONIC DEVICE HAVING SAME 덕산네오룩스 주식회사 2021-07-29 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230183201-A1 COMPOUND FOR ORGANIC ELECTRIC ELEMENT, ORGANIC ELECTRIC ELEMENT USING SAME, AND ELECTRONIC DEVICE HAVING SAME ORAI2, OR10J3, OR51E2 GABRG2 3842/4885GABRB3 4539/4885GABRA5 4491/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.